# Comparison of Continuous Intravenous Lidocaine Infusion Versus ESP Block for Rib Fracture Analgesia

> **NCT04707183** · PHASE2 · WITHDRAWN · sponsor: **Stanford University**

## Conditions studied

- Rib Fractures

## Interventions

- **DRUG:** Lidocaine IV Infusion
- **DRUG:** 2% Lidocaine via ESPB

## Key facts

- **NCT ID:** NCT04707183
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-05
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04707183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04707183, "Comparison of Continuous Intravenous Lidocaine Infusion Versus ESP Block for Rib Fracture Analgesia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04707183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*